Thank you to those that attended our 9th Annual CE Event-- New Therapies for Lymphoma: Monoclonal Antibodies and Beyond presented by Gerald Post, DVM,MEM,DACVIM(Oncology) and Advances in Radiation Therapy for Nasal Tumors in Dogs and Cats presented by John Farrelly, DVM, DACVIM (Oncology) DACVR (Radiation Oncology). A very special thank you to John Gerecitano, MD, PhD, who is the Clinical Director of Lymphoma Outpatient Services and a member of the Developmental Therapeutics Group at Memorial Sloan-Kettering Cancer Center. It was a special treat to hear about state-of-the-art therapy for lymphoma in people
We hope you found the speakers and the topics to be both informative and beneficial. These continuing education events are part of our ongoing effort to provide you, your clients and their pets with the optimal care. Your attendance and support of The Veterinary Cancer Center is very important to us and are what helps to make these events successful.
For those of you that missed this year's CE we have taken the liberty of posting the slides, as well as the lecture booklet, on our website (www.VCChope.com) for your review or you can simple click on the links below. If you would like any additional information about the CE content please feel free to call us directly at 203-838-6626. Printed copies are available upon request.
As a follow up to this year’s CE we will be providing a lecture, “The Future of Radiation Therapy for Your Patients”, on Thursday, May 28th from 6-7:30pm at The Veterinary Cancer Center to a small group of veterinarians. This will enable us to elaborate how stereotactic radiation therapy and IMRT can be beneficial for both your clients and your patients. (more info included below)
At a later date we will be sending out more complete information about the results of our Quality of Life Survey, which Dr. Post briefly discussed at this year’s CE. This survey is given to every client at every visit and the preliminary results show that we are indeed improving your patient’s quality of life, both during and after therapy.
Lastly, we would also like to thank Aratana, IDEXX, Blue Buffalo, Zoetis, and all our sponsors. Their generous support has allowed us to not charge any registration fees to attendees as well as enabling all of us to enjoy such venus as the beautiful Stamford Yacht Club. Without their support we would not be able to offer a CE event of this quality.
Please feel free to contact Steven Bonell or Jerold Willams at (203) 838-6626 any time if you have questions; to learn more about our premier sponsor Aratana; or learn more about the numerous clinical trials being offered at The VCC. We look forward to working with you again in the future.
SAVE THE DATE
NETWORKING AND EDUCATIONAL EVENT FOR VETERINARIANS
Thursday, May 28th from 6-7:30pm
The Veterinary Cancer Center ● 129 Glover Avenue ● Norwalk ● CT ● 06850
PLEASE RSVP BY MAY 27TH
The Future of Radiation Therapy for Your Patients:
Understand what new technologies are available
Learn what treatment is right for your clients and your patients
Discover how new technologies can decrease side effects AND increase tumor control
Email: email@example.com or call 203.838.6626
Please include your name, hospital name, and email address.
Seating is limited to the first 30 individuals.
The VCC will be providing lite fare, drinks and several door prizes
The VCC is very excited to be presenting the 9th Annual Continuing Education Lecture on "New Therapies for Lymphoma and Advances in Radiation Therapy for Nasal Tumors". We have always strived for excellence in everything that we do and this event will be no different. Due to the quality of the venue, support staff, and wonderful food we will once again be hosting the event at the beautiful Stamford Yacht Club. For those that missed the event last year you are in for a wonderful and educational experience. - To register click here
We will also are very excited to have a special guest speaker John Gerecitano, MD, PhD, who is a Medical Oncologist on the Lymphoma Service at the Memorial Sloan-Kettering Cancer Center, where he serves as the principal investigator in phase I and phase II clinical trials in the development of new lymphoma treatments. He will give a brief presentation about the value of monoclonal antibodies in the treatment of lymphoma in people.
This is a free dinner lecture, space will be limited to the first 125 registrants, so please register by April 10th, 2015! Additional details are below.
Date and Time: April 29th from 6-9pm
Place: Stamford Yacht Club - 97 Ocean Drive West • Stamford, CT
For directions go to www.stamfordyc.com
Please include your name, practice name, and email address with food selection of chicken, fish or vegetarian- exact menu items will be posted shorly.
Cost: Free - In order to be considered for future events please be courteous and give at least two weeks’ notice if you RSVP and cannot attend so that others can attend in your place.
Summary of lectures can be found below:
Part One: New Therapies for Lymphoma: Monoclonal Antibodies and Beyond (Dr. Post)
Lymphoma is one of the most common cancers in both dogs and cats. This lecture will discuss new therapeutic options available for the treatment of this cancer. We will discuss monoclonal antibody therapy for both T and B cell lymphoma in dogs along with new chemotherapeutic options.
Summary: This lecture will outline the advances being made in the treatment of lymphoma in pets. Therapeutic options, including monoclonal antibodies, new chemotherapeutic agents and multi-modality therapy will be discussed.
Part Two: Advances in Radiation Therapy for Nasal Tumors in Dogs and Cats (Dr. Farrelly)
This lecture will discuss the historical treatment of nasal tumors, as well as recent advances over the past 10 to 15 years, including how these advances have decreased side effects and increased options available to pet owners whose pets have nasal tumors.
Summary: This lecture will outline the advances in radiation therapy that can be useful for treating dogs and cats with nasal tumors. It will review the history of treatment for this disease along with the major strides that have been made over the past 10-15 years that allow for a much more precise treatment, with minimal side effects. It will also discuss how these advances can be applied to palliative treatment for nasal tumors.
To register: online click here